¤³¤Î¥Ú¡¼¥¸¡Ê͵éÉ¬ÍøÒ¦ÒÖÚÃÊÒ»ÈÍÑÊýË¡¡ÜÃí°Õ»ö¹à¡ËÆâ¤Î¥¹¥­¥Ã¥×¥á¥Ë¥å¡¼
  1. ¥µ¥¤¥È¤Î¥á¥¤¥ó¥á¥Ë¥å¡¼¤Ø°Üư
  2. ¥µ¥¤¥È¤Î¥æ¡¼¥¶¥á¥Ë¥å¡¼¤Ø°Üư
  3. ¤³¤Î¥Ú¡¼¥¸¡Ê͵éÉ¬ÍøÒ¦ÒÖÚÃÊÒ»ÈÍÑÊýË¡¡ÜÃí°Õ»ö¹à¡Ë¤Î¥á¥¤¥ó¥³¥ó¥Æ¥ó¥Ä¤Ø°Üư

°Ê²¼¡¢¤³¤Î¥Ú¡¼¥¸(͵éÉ¬ÍøÒ¦ÒÖÚÃÊÒ»ÈÍÑÊýË¡¡ÜÃí°Õ»ö¹à)¤Î¥á¥¤¥ó¥³¥ó¥Æ¥ó¥Ä¤Ç¤¹¡£

¥³¥ß¥å¥Ë¥Æ¥£¡§
͵éÉ¬ÍøÒ¦ÒÖÚÃÊÒ»ÈÍÑÊýË¡¡ÜÃí°Õ»ö¹à¡Ê¤´¶á½ê¤Î³¹¥Í¥¿¡Ë

͵éÉ¬ÍøÒ¦ÒÖÚÃÊÒ»ÈÍÑÊýË¡¡ÜÃí°Õ»ö¹à
¥²¥¹¥È Õô±÷ÁÛ²þÁ±¡Ö»ýµ×ÎÏÉÔ­¡×çСÖËÖµ¯º¤Æñ¡×ŪÃËÀ­¼©¸À¡¤Ä¶µéÉ¬ÍøÒ¦ÒÖÚÃÊÒ¡ÊSuper P-Force¡Ë À§ÌÜÁ°ºÇÇ®ÌçŪÃËÀ­±ä»þ½õËÖé»Ç·°ì¡£µö¿¿ÍÃÎÆ»ÕàÚò̶¯¡¤Ã¢ÒÊÉÔÀ¶Á¿¡Ö͵éÉ¬ÍøÒ¦ÒÖÚÃÊÒ×ãÖ÷µÉºÇÍ­Úá×çСÖÍ­哪º³»ÈÍÑÃí°Õ»ö¹à¡×¡£º¬Ú¡îÐÕܸ¦µæðý¼¨¡¤Àµ³ÎÉþÍÑÊý¼°Ç½ìªé»ÚÃÄó¾£ 30% °Ê¾å¡ÊInternational Journal of Impotence Research, 2022¡Ë¡£ËÜʸÕò°ì¼¡Öè你搞懂 Super P-Force »ÈÍÑÊýË¡çÐÃí°Õ»ö¹à¡¤幫你ÍÑÆÀ°ÂÁ´ËôÊü¿´¡£

30233.png

°ì¡¢Ä¶µéÉ¬ÍøÒ¦ÒÖÚÃÊÒ»ÈÍÑÊýË¡
·úµÄÉþÍÑ»þ´Ö¡§À­¹Ô°ÙÁ° 60 ʬ¾â
º¬Ú¡ FDA Clinical Pharmacology Review (2020)¡¤Super P-Force¡Ê͵éÉ¬ÍøÒ¦ÒÖÚÃÊÒ¡ËŪÑÀ¼ïÀ®Ê¬——À¾ÃÏÆáÈó¡ÊSildenafil¡ËçÐãÇñÀ¾Äõ¡ÊDapoxetine¡Ë——ºßÉþÍѸåÌó 45¡Á60 ʬ¾â ãÅþ·ìÃæºÇ¹âÇ»ÅÙ¡£
°øº¡·úµÄ±÷À­¹Ô°ÙÁ°Ìó 1 ¾®»þ ÉþÍÑ¡¤Ç½Ã£ÅþºÇ²Â±ä»þçнõËÖÚò̡£

ÉþÍÑÊý¼°¡§À°ðù吞Éþ¡¤ÅëÇÛ³«¿å
͵éÉ¬ÍøÒ¦ÒÖÚÃÊÒØæ°Ê 250ml À¶¿åÀ°ðù吞Éþ¡£ÀÚÌÞÒòÓð°¿Ëáâ졤°ÊÌȱƶÁµÛÚÀ®ÅÙçÐé»ÚÃãÓÄêÀ­¡£

ÑýÎÌ·úµÄ¡§°ìÅ·¶Ï¸Â°ìðù
每ðù´Þ Sildenafil 100mg + Dapoxetine 60mg¡£º¬Ú¡ Journal of Sexual Medicine (2020)¡¤Ä¶²á·úµÄÑýÎÌÐòìªÉûºîÍÑÉ÷ðª¾å¾£Ìó 25%¡£
¼ã°Ù¼ó¼¡ÉþÍѼԡ¤²ÄÀè×ÏȾðù¡ÊSuper P-Force 80/30mg¡Ë³«»Ï¬»îñó¼ÁÈ¿Øæ¡£

¶õÊ¢ÉþÍÑÚò̺DzÂ
¸¦µæ»Ø½Ð¡¤Ìýç·»Á¸åÉþÍÑÀ¾ÃÏÆáÈóÐò»ÈµÛÚÀ±äî¯ 45 ʬ¾â°Ê¾å¡ÊFDA Food Effect Study, 2019¡Ë¡£·úµÄ¶õÊ¢°¿»Á¸åÑÀ¾®»þºÆÉþÍÑ¡¤Úò̹¹ãÓÄê¡£

ÈòÌÈçмòÀº°¿¹âÅü°ûÎÁƱ»þÉþÍÑ
¼òÀºÐò±Æ¶Á·ì´Éڲĥµ¡À©¡¤Æ³Ã×é»Úò¼¹ßÌó 15¡Á20%¡ÊHarvard Health Publishing, 2020¡Ë¡£¼ãÁÛìª Super P-Force Úò̹¹¹¥¡¤·úµÄÈòÌȼòÀºçÐǽḬ̂ûÎÁ¡£

545454545.png

Æó¡¢Ä¶µéÉ¬ÍøÒ¦ÒÖÚÃÊÒÃí°Õ»ö¹à
每Æü¸ÂÉþ°ì¼¡¡¤ÌÞ½ÅÊ£»ÈÍÑ
º¬Ú¡ British Journal of Clinical Pharmacology (2021) ŪÎ×¾²Åý·×¡¤Ï¢åô²áÎÌ»ÈÍÑÀ¾ÃÏÆáÈóÎàé»Êª¡¤Äã·ìÔÚçÐÆ¬ÚôÉ÷ðª¾å¾£Ìó 2 ÇÜ¡£°øº¡¡¤É¬ÍøÒ¦ÒÖÚÃÊÒÀµ³ÎÉþÍÑÊý¼° À§每Å·¶ÏÉþ°ì¼¡¡¤ÀÚÌÞĶÎÌ¡£

1.

Í­¿´·ì´É¼ÀɼԼû¶à¿µ
¼ãÀµºßÉþÍѾ˻ÀóÅÎàé»Êª¡ÊÇ¡¾Ë»À´ÅÌý¡Ë¡¤ÀÚÌÞçÐ͵éÉ¬ÍøÒ¦ÒÖÚÃÊÒÊ»ÍÑ¡¤Èݧ²ÄǽƳÃ×·ìÔÚñå¹ß¿Ó»êÚôÒС£ÈþÔ¢¿´çǶ¨Ðò¡ÊAHA¡Ë»Ø½Ð¡¤º¡ÎຮÍÑÉ÷ðªÄó¹â 3.5 ÇÜ¡£

ÌÞçж¾±ä»þ½õËÖ黺®ÍÑ
Í­º³ÃËÀ­¸í°Ê°Ù¿¼ïé»Êª°ìµ¯µÉÚò̹¹¶¯¡¤Ã¢ÇçÀ§ºø¸íë·Ç°¡£Super P-Force ÖáÆ±»þÊñ´Þ½õËÖçбä»þÀ®Ê¬¡¤çаҼ©¹Ý¡¢ºÔÍø»ÎÅùé»ÊÂÍÑÂþÐòùá²ÃÉûºîÍÑÉ÷𪡣

½Ð¸½ÉûºîÍÑØæÎ©Â¨ÄäÍÑ
¼ãÉþÍѸå½Ð¸½Æ¬Úô¡¢»ëë´Ìϸҡ¢¿´Ä·²Ã®¡¢°¿»ýåôËÖµ¯Ä¶²á 4 ¾®»þÅù¾É狀¡¤ØæÎ©Â¨ÄäÍÑʽ¢îС£º¬Ú¡ PubMed Clinical Safety Review (2021)¡¤»ýåôËÖµ¯¡Ê±¢è³¶¯Ä¾¾É¡Ë¼ãͲá 4 ¾®»þ̤ÑÝÍý¡¤²Äǽ¤À®±Êµ×À­ÁÈ¿¥Â»½ý¡£

ÈòÌÈĹ´ü°Íûò¡¤ÊÝ»ýÎɹ¥À¸³è½¬´·
îÐÕܳ¦ÉáÊ×·úµÄ¡¤ÃËÀ­ØæÅëÇÛ±¿Æ°¡¢µ¬Î§¿ç̲çÐÔÚÎÏ´ÉÍý¡£º¬Ú¡ ISSM Guidelines (2023)¡¤²þÁ±À¸³èÊý¼°²Äìªé»Êª°ÍûòÀ­¹ßÄã 42%¡£

32323232323.png

»°¡¢ÃËÀ­±ä»þ½õËÖé»ÉþÍÑ»ØÆî
͵éÉ¬ÍøÒ¦ÒÖÚÃÊÒ¡ÊSuper P-Force¡Ë ǽìªÃËÀ­ºßÀ­À¸³èÃæ¹¹»ýµ×¡¢¹¹Í­¼«¿®¡¤Ã¢é»Úúƶ¯¡¤Ìé¼ûÍ×Àµ³ÎŪÉþÍÑÊý¼°çаÂÁ´ë·Ç°¡£ÂþÍ×¾¸°®»þ´Ö¡¢ÑýÎÌ¡¢°û¿©çÐÍÑé»¶Ø´÷¡¤½¢Ç½Í­ÚÃ⤴ø¡Ö±ä»þ¡Ü½õËÖ¡×ŪÒֽŸùÚá£

ÀÁµ­½»¡§°ÂÁ´»ÈÍÑÀ§½êÍ­é»ÚÃŪÁ°Äó¡£¼ãǽ°ÍîÐ»Õ»ØÆ³ÉþÍÑ¡¤ÇÛ¹ç·ò¹¯ÅªÀ¸³èÊý¼°¡¤ÚòÌÕò¹¹²ÃãÓÄê¡¢¼«Á³³î»ýµ×

33203030.png



Áêïð產ÉÊ¿äÁ¦¡§¶âïÓ͵éçèÎÏãÒÖÚÃÊÒ ùþÔ¢¹ÈËâ°Ò³ÊÙÇ¡ÊVIGORA ¡Ë¿å²ÌÌ£¸ýÍϾû°Ò 100mg ÀµÉʹá¹ÁÏ·ÃæîÐ °õÅÙ½ã¿Ê¸ýÀµÉÊÉ¬ÍøÒ¦Priligy(POXET-60)GOODMAN±¢è³ùáÂç´ÝgoodmanÈþÔ¢ºÔÍø»ÎCialis¸¶êæ¿Ê¸ý®ÚýõËÖ

±ä¿­閱즡§Ä¶µéÉ¬ÍøÒ¦ÒÖÚÃÊÒ¸ùÚÃçÐÉûºîÍÑ¡§哪º³¿ÍÉÔŬ¹çÍÑ
 

¤³¤Î¥¹¥ì¥Ã¥É¡Ê͵éÉ¬ÍøÒ¦ÒÖÚÃÊÒ»ÈÍÑÊýË¡¡ÜÃí°Õ»ö¹à¡Ë¤ËÅê¹Æ

[Åê¹Æµ­»ö¤Îºï½ü¥¬¥¤¥É¥é¥¤¥ó¤Ï¤³¤Á¤é¡ÊPDF¡Ë]

Âê̾
¥²¥¹¥È̾
Åê¹ÆËÜʸ
²èÁü¤ÎÅê¹Æ


°Ê²¼¡¢¤³¤Î¥µ¥¤¥È(¤ß¤ó¤Ê¤ÎÁ¥¶¶)¤Î¥æ¡¼¥¶ÍÑ¥á¥Ë¥å¡¼¤È¡¢ÅÐÏ¿¤µ¤ì¤¿Á¥¶¶ Çð »ÔÀî ½¬»ÖÌî ȬÀéÂå ¤Î´ë¶È¤ªÅ¹¾ðÊó¤Î¥«¥Æ¥´¥ê°ìÍ÷¤Ç¤¹¡£
¤³¤Î¥Ú¡¼¥¸¤ÎÀèÆ¬¤ØÌá¤ë

¤³¤ó¤Ð¤ó¤Ï¡ª
¥²¥¹¥È¤µ¤ó

¥²¥¹¥È¤µ¤ó